Through its engagement with key receptors, notably TLR4 and CAP-1, resistin activates a cascade of proinflammatory signaling pathways, including NF-κB and MAPK, which drive endothelial dysfunction, promote leukocyte adhesion and migration, and initiate early atherosclerotic processes. This evidence concerns the gene CAP1 and endothelial dysfunction.